Melanoma cells can be eliminated by sialylated CD43 × CD3 bispecific T cell engager formats in vitro and in vivo
de Jong, G., Bartels, L., Kedde, M., Verdegaal, E. M. E., Gillissen, M. A., Levie, S. E., Cercel, M. G., van Hal-van Veen, S. E., Fatmawati, C., van de Berg, D., Yasuda, E., Claassen, Y. B., Bakker, A. Q., van der Burg, S. H., Schotte, R., Villaudy, J., Spits, H., Hazenberg, M. D., van Helden, P. M., Wagner, K.
Published in Cancer Immunology, Immunotherapy (01.06.2021)
Published in Cancer Immunology, Immunotherapy (01.06.2021)
Get full text
Journal Article
The modified FACS calcein AM retention assay: A high throughput flow cytometer based method to measure cytotoxicity
Gillissen, M.A., Yasuda, E., de Jong, G., Levie, S.E., Go, D., Spits, H., van Helden, P.M., Hazenberg, M.D.
Published in Journal of immunological methods (01.07.2016)
Published in Journal of immunological methods (01.07.2016)
Get full text
Journal Article
AML relapse after rituximab treatment for GvHD: crucial role for B cells in GvL responses
Gillissen, M A, de Jong, G, Levie, S E, Yasuda, E, Bakker, A Q, Evers, L M, Pals, S T, Huisman, C, van Helden, P M, Spits, H, Hazenberg, M D
Published in Bone marrow transplantation (Basingstoke) (01.09.2016)
Published in Bone marrow transplantation (Basingstoke) (01.09.2016)
Get full text
Journal Article
Tumour-reactive B cells and antibody responses after allogeneic haematopoietic cell transplantation
de Jong, G., Gillissen, M.A., Spits, H., Hazenberg, M.D.
Published in Immuno-oncology technology (01.09.2020)
Published in Immuno-oncology technology (01.09.2020)
Get full text
Journal Article
AML relapse after rituximab treatment for GvHD: crucial role for B cells in GvL responses
Gillissen, M A, de Jong, G, Levie, S E, Yasuda, E, Bakker, A Q, Evers, L M, Pals, S T, Huisman, C, van Helden, P M, Spits, H, Hazenberg, M D
Published in Bone marrow transplantation (01.09.2016)
Published in Bone marrow transplantation (01.09.2016)
Get full text
Report